KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) Net Margin (2020 - 2024)

Clover Health Investments (CLOV) has disclosed Net Margin for 5 consecutive years, with 0.19% as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Net Margin changed N/A year-over-year to 0.19%, compared with a TTM value of 0.04% through Sep 2025, down 41.0%, and an annual FY2024 reading of 0.24%, up 1321.0% over the prior year.
  • Net Margin was 0.19% for Q4 2024 at Clover Health Investments, down from 0.11% in the prior quarter.
  • Across five years, Net Margin topped out at 11.31% in Q4 2020 and bottomed at 73.49% in Q3 2021.
  • Average Net Margin over 5 years is 13.61%, with a median of 5.19% recorded in 2022.
  • The sharpest move saw Net Margin crashed -7212bps in 2021, then surged 6830bps in 2022.
  • Year by year, Net Margin stood at 11.31% in 2020, then tumbled by -352bps to 28.55% in 2021, then soared by 58bps to 11.88% in 2022, then rose by 28bps to 8.6% in 2023, then surged by 98bps to 0.19% in 2024.
  • Business Quant data shows Net Margin for CLOV at 0.19% in Q4 2024, 0.11% in Q3 2024, and 0.06% in Q2 2024.